Understanding the Effect of API Properties on Bioavailability Through Absorption Modeling
暂无分享,去创建一个
[1] R. J. Hintz,et al. The effect of particle size distribution on dissolution rate and oral absorption , 1989 .
[2] Michael Brandl,et al. Physicochemical Properties of the Nucleoside Prodrug R1626 Leading to High Oral Bioavailability , 2008 .
[3] Lawrence X. Yu,et al. In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome. , 2004, Current opinion in drug discovery & development.
[4] Rainer H. Müller,et al. Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique , 1998 .
[5] G. Amidon,et al. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. , 2004, Molecular pharmaceutics.
[6] A. Noyes,et al. The rate of solution of solid substances in their own solutions , 1897 .
[7] Michael B. Bolger,et al. Application of Gastrointestinal Simulation for Extensions for Biowaivers of Highly Permeable Compounds , 2008, The AAPS Journal.
[8] Kiyohiko Sugano,et al. Theoretical dissolution model of poly-disperse drug particles in biorelevant media. , 2008, Journal of pharmaceutical sciences.
[9] Lawrence X. Yu,et al. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. , 2006, Molecular pharmaceutics.
[10] Lawrence X. Yu. An Integrated Model for Determining Causes of Poor Oral Drug Absorption , 1999, Pharmaceutical Research.
[11] J. Dressman,et al. Mixing-tank model for predicting dissolution rate control or oral absorption. , 1986, Journal of pharmaceutical sciences.
[12] J Dressman,et al. Improving drug solubility for oral delivery using solid dispersions. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[13] Gloria Kwei,et al. The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human. , 2004, International journal of pharmaceutics.
[14] G L Amidon,et al. Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption. , 1996, Advanced drug delivery reviews.
[15] Filippos Kesisoglou,et al. Nanosizing--oral formulation development and biopharmaceutical evaluation. , 2007, Advanced drug delivery reviews.
[16] Yatindra Joshi,et al. Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system. , 2004, Journal of pharmaceutical sciences.
[17] Erich Brunner,et al. Reaktionsgeschwindigkeit in heterogenen Systemen , 1904 .
[18] D. Flanagan,et al. General solution for diffusion-controlled dissolution of spherical particles. 1. Theory. , 1999, Journal of pharmaceutical sciences.
[19] Martin Kuentz,et al. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[20] Walter Schmitt,et al. PK-Sim®: a physiologically based pharmacokinetic ‘whole-body’ model , 2003 .
[21] B Agoram,et al. Predicting the impact of physiological and biochemical processes on oral drug bioavailability. , 2001, Advanced drug delivery reviews.
[22] Jennifer B Dressman,et al. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[23] G. Amidon,et al. Absorption potential: estimating the fraction absorbed for orally administered compounds. , 1985, Journal of pharmaceutical sciences.
[24] Abu T M Serajuddin,et al. Salt formation to improve drug solubility. , 2007, Advanced drug delivery reviews.
[25] Kevin C. Johnson,et al. Guidance in the Setting of Drug Particle Size Specifications to Minimize Variability in Absorption , 1996, Pharmaceutical Research.
[26] Kevin C. Johnson,et al. Dissolution Modeling: Factors Affecting the Dissolution Rates of Polydisperse Powders , 1993, Pharmaceutical Research.
[27] W. Nernst,et al. Theorie der Reaktionsgeschwindigkeit in heterogenen Systemen , 1904 .